Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The generation of Synthetic Computed Tomography (sCT) images has become a pivotal methodology in modern clinical practice, particularly in the context of Radiotherapy (RT) treatment planning. The use of sCT enables the calculation of doses, pushing towards Magnetic Resonance Imaging (MRI) guided radiotherapy treatments. Moreover, with the introduction of MRI-Positron Emission Tomography (PET) hybrid scanners, the derivation of sCT from MRI can improve the attenuation correction of PET images. Deep learning methods for MRI-to-sCT have shown promising results, but their reliance on single-centre training dataset limits generalisation capabilities to diverse clinical settings. Moreover, creating centralised multi-centre datasets may pose privacy concerns. To address the aforementioned issues, we introduced FedSynthCT-Brain, an approach based on the Federated Learning (FL) paradigm for MRI-to-sCT in brain imaging. This is among the first applications of FL for MRI-to-sCT, employing a cross-silo horizontal FL approach that allows multiple centres to collaboratively train a U-Net-based deep learning model. We validated our method using real multicentre data from four European and American centres, simulating heterogeneous scanner types and acquisition modalities, and tested its performance on an independent dataset from a centre outside the federation. In the case of the unseen centre, the federated model achieved a median Mean Absolute Error (MAE) of 102.0 HU across 23 patients, with an interquartile range of 96.7-110.5 HU. The median (interquartile range) for the Structural Similarity Index (SSIM) and the Peak Signal to Noise Ratio (PNSR) were 0.89 (0.86-0.89) and 26.58 (25.52-27.42), respectively. The analysis of the results showed acceptable performances of the federated approach, thus highlighting the potential of FL to enhance MRI-to-sCT to improve generalisability and advancing safe and equitable clinical applications while fostering collaboration and preserving data privacy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.compbiomed.2025.110160DOI Listing

Publication Analysis

Top Keywords

federated learning
8
deep learning
8
interquartile range
8
fedsynthct-brain federated
4
learning
4
learning framework
4
framework multi-institutional
4
multi-institutional brain
4
brain mri-to-ct
4
mri-to-ct synthesis
4

Similar Publications

Learning from history for personalized federated learning.

Neural Netw

September 2025

College of Information Science, North China University of Technology, Beijing, China. Electronic address:

Personalized Federated Learning (pFL) has received extensive attentions, due to its ability to effectively process non-IID data distributed among different clients. However, most of the existing pFL methods focus on the collaboration between global and local models to enrich the personalization process, but ignoring a lot of valuable historical information, which represents the unique learning trajectory of each client. In this paper, we propose a pFL method called FedLFH, which introduces a tracking variable that allows each client to preserve historical information to facilitate personalization.

View Article and Find Full Text PDF

Applications of Federated Large Language Model for Adverse Drug Reactions Prediction: Scoping Review.

J Med Internet Res

September 2025

Department of Information Systems and Cybersecurity, The University of Texas at San Antonio, 1 UTSA Circle, San Antonio, TX, 78249, United States, 1 (210) 458-6300.

Background: Adverse drug reactions (ADR) present significant challenges in health care, where early prevention is vital for effective treatment and patient safety. Traditional supervised learning methods struggle to address heterogeneous health care data due to their unstructured nature, regulatory constraints, and restricted access to sensitive personal identifiable information.

Objective: This review aims to explore the potential of federated learning (FL) combined with natural language processing and large language models (LLMs) to enhance ADR prediction.

View Article and Find Full Text PDF

Protein kinases are central regulators of cell signaling and play pivotal roles in a wide array of diseases, most notably cancer and autoimmune disorders. The clinical success of kinase inhibitors-such as imatinib and osimertinib-has firmly established kinases as valuable drug targets. However, the development of selective, potent inhibitors remains challenging due to the conserved nature of the ATP-binding site, off-target effects, resistance mutations, and patient-specific variability.

View Article and Find Full Text PDF

Large-scale genomics data combined with Electronic Health Records (EHRs) illuminate the path towards personalized disease management and enhanced medical interventions. However, the absence of "gold standard" disease labels makes the development of machine learning models a challenging task. Additionally, imbalances in demographic representation within datasets compromise the development of unbiased healthcare solutions.

View Article and Find Full Text PDF

Early diagnosis of Parkinson's disease (PD) is crucial for timely treatment and disease management. Recent studies link PD to impaired facial muscle control, manifesting as "masked face" symptoms, offering a novel diagnostic approach through facial expression analysis. However, data privacy concerns and legal restrictions have resulted in significant "data silos", hindering data sharing and limiting the accuracy and generalizability of existing diagnostic models due to small, localized datasets.

View Article and Find Full Text PDF